# Final Remediation Report

## executive summary
The selected expanded-capability production-readiness findings were remediated with targeted hardening changes to dispatch policy metadata, internal orchestration telemetry taxonomy, and integration evidence depth. Safety boundaries remain fail-closed and no destructive capabilities were introduced.

## audit set consumed
- latest complete set: `20260306T152446Z` under `docs/audit/production-readiness-expanded-capabilities/`.

## findings remediated
- `SH-MED-004` (capability-class authz metadata)
- `SH-MED-005` (non-mocked delegated orchestration integration depth)
- `OP-MED-001` (internal orchestration contract-failure taxonomy)

## findings deferred
- none from this remediation run.

## tests and validations added
- new class-policy denial test and non-mocked delegated orchestration integration test.
- observability and healthcheck tests updated for new metadata/telemetry surfaces.
- full rerun: `223 passed, 2 skipped`.

## readiness score impact
- expected improvement in hardening and operability dimensions.
- no regression evidence from suite rerun.

## remaining blockers
- no open production blockers in this remediation scope.

## recommended rollout class
- `Internal Pilot Ready with Conditions`

## what is safe now
- explicit class-aware dispatch policy with optional class restrictions.
- deterministic internal contract-failure reason taxonomy for operator triage.
- delegated orchestration contract continuity validated through real execute-tool routing in CI-safe runtime.

## what remains lab-only
- active validation/probe/chaos/self-healing mutation flows remain lab-gated by mode, env flags, and target eligibility (`environment=lab`, `allow_active_validation=true`, `safety_tier=lab_safe`).

## what still must not ship
- any rollout that disables existing mode/write-intent/allowlist/target-eligibility controls.
- any production activation of active mutation flows without explicit lab-safe gating exceptions and governance approval.
